Neoadjuvant Immunotherapy for NSCLC: A New Frontier

Episode
68
Soundcloud
Share

In this episode of Lung Cancer Considered, host Dr. Narjust Duma discusses the use of neoadjuvant immunotherapy, through a multidisciplinary lens, with guests Dr. Leah Backhus and Dr. Patrick Forde.

Guest
Narjust Florez
Narjust Florez

MD

Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Patrick Forde
Patrick Forde

M.B.B.Ch.

Director of Thoracic Oncology - Clinical Research Program and Associate Professor
John Hopkins University
Leah Backhus
Leah Backhus

MD MPH FACS

Associate Professor of Cardiothoracic Surgery
Division of Thoracic Surgery at Stanford Healthcare and Palo Alto Veterans Affairs Health Care System
Related ILCN article